Clinical trial
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in Middle-to-late Stages of Chronic Kidney Disease Patients: a Multi-center Randomized Controlled Study
NCT02944214 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compare the Renal Protective Effects of Febuxostat and Benzbromarone in Middle-to-late Stages of Chronic Kidney Disease Patients: a Multi-center Randomized Controlled Study
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- December 31, 2019
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abnormal renal function, chronic kidney disease, hyperuricemia